Literature DB >> 18335224

Activity of paclitaxel in metastatic squamous anal carcinoma.

Thierry Alcindor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18335224     DOI： 10.1007/s00384-008-0467-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  11 in total

Review 1.  Pharmacotherapy of Anal Cancer.

Authors:  Jane E Rogers; Cathy Eng
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Successful treatment of anal carcinoma with Paclitaxel, Cisplatin, and radiotherapy in a patient who developed a coronary syndrome from 5-fu.

Authors:  Shalini Garg; Ross A Abrams; William T Leslie
Journal:  Gastrointest Cancer Res       Date:  2012-07

Review 3.  Systemic Therapies for Advanced Squamous Cell Anal Cancer.

Authors:  Francesco Sclafani; Sheela Rao
Journal:  Curr Oncol Rep       Date:  2018-05-04       Impact factor: 5.075

4.  FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.

Authors:  Sebastian Mondaca; Walid K Chatila; David Bates; Jaclyn F Hechtman; Andrea Cercek; Neil H Segal; Zsofia K Stadler; Anna M Varghese; Ritika Kundra; Marinela Capanu; Jinru Shia; Nikolaus Schultz; Leonard Saltz; Rona Yaeger
Journal:  Clin Colorectal Cancer       Date:  2018-09-21       Impact factor: 4.481

5.  Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.

Authors:  Francesco Sclafani; Federica Morano; David Cunningham; Chiara Baratelli; Eleftheria Kalaitzaki; David Watkins; Naureen Starling; Ian Chau; Sheela Rao
Journal:  Oncologist       Date:  2017-02-16

6.  Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.

Authors:  Katsuji Sawai; Takanori Goi; Noriyuki Tagai; Hidetaka Kurebayashi; Mitsuhiro Morikawa; Kenji Koneri; Masato Tamaki; Makoto Murakami; Yasuo Hirono; Hiroyuki Maeda
Journal:  Surg Case Rep       Date:  2022-06-20

7.  Treatment options in metastatic squamous cell carcinoma of the anal canal.

Authors:  Cathy Eng; Priyanka Pathak
Journal:  Curr Treat Options Oncol       Date:  2009-05-29

8.  The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.

Authors:  Cathy Eng; George J Chang; Y Nancy You; Prajnan Das; Miguel Rodriguez-Bigas; Yan Xing; Jean-Nicolas Vauthey; Jane E Rogers; Aki Ohinata; Priyanka Pathak; Salil Sethi; Jonathan K Phillips; Christopher H Crane; Robert A Wolff
Journal:  Oncotarget       Date:  2014-11-30

9.  Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

Authors:  Stefano Kim; Marine Jary; Thierry André; Véronique Vendrely; Bruno Buecher; Eric François; François-Clément Bidard; Sarah Dumont; Emmanuelle Samalin; Didier Peiffert; Simon Pernot; Nabil Baba-Hamed; Farid El Hajbi; Olivier Bouché; Jérôme Desrame; Aurélie Parzy; Mustapha Zoubir; Christophe Louvet; Jean-Baptiste Bachet; Thierry Nguyen; Meher Ben Abdelghani; Denis Smith; Christelle De La Fouchardière; Thomas Aparicio; Jaafar Bennouna; Jean-Marc Gornet; Marion Jacquin; Franck Bonnetain; Christophe Borg
Journal:  BMC Cancer       Date:  2017-08-25       Impact factor: 4.430

10.  Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.

Authors:  Ninoska N Silva; Cathy Eng
Journal:  J Adv Pract Oncol       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.